Beware of Eli Lilly, this pharmaceutical giant is the best player in obesity market
Eli Lilly today is the dominant player of the GLP-1 drug market. It has a pair of GLP-1 products that make up more than half of its top line. Competition in this space is growing, including from the best pharmaceutical companies. 10 shares we like more than Eli Lilly › Eli Lilly (NYS: LLY) There … Read more